Vascular effects of combined enriched Korean Red ginseng (Panax Ginseng) and American ginseng (Panax Quinquefolius) administration in individuals with hypertension and type 2 diabetes: A randomized controlled trial

Complementary Therapies in Medicine
Elena JovanovskiVladimir Vuksan

Abstract

Type 2 diabetes is known to abrogate the vascular response. Combination of two commonly consumed ginseng species, American ginseng (AG) and a Korean Red ginseng (KRG), enriched with ginsensoide Rg3, was shown to concomitantly improve glucemic control and blood pressure. We evaluated the hypothesis that improvements in central hemodynamics, vascular function and stiffness markers are involved in observed benefits of co-administration. In this randomized, placebo controlled, two-center trial, patients with type 2 diabetes and hypertension were assigned to either 2.25 g ginsenoside Rg3-enriched KRG&AG co-administration or a control 3 times daily for 12-weeks, treated by standard of care. The effects on central hemodynamics, pulse wave velocity (PWV) and endothelial function over the 12-week administration were analyzed. In intent-to-treat analysis of 80 individuals, a reduction in central systolic BP (-4.69 ± 2.24 mmHg, p = 0.04) was observed with co-administration of Rg3-KRG + AG relative to control at 12-weeks, which was characterized by a decrease in end-systolic pressure (-6.60 ± 2.5 mmHg, p = 0.01) and area under the systolic/diastolic BP curve (-132.80 ± 65.1, p = 0.04, 220.90 ± 91.1, p = 0.02, respectively). There was no si...Continue Reading

References

Mar 19, 1999·European Journal of Pharmacology·N D KimV B Schini-Kerth
Dec 12, 2001·Journal of the American College of Cardiology·C H ChenD A Kass
Jul 2, 2003·Sangyō eiseigaku zasshi = Journal of occupational health·Masahiko Saito, Ayumi Kasuya
Dec 8, 2004·Journal of the American College of Cardiology·Piero O BonettiAmir Lerman
Sep 29, 2005·European Journal of Heart Failure·Gary F MitchellMarc A Pfeffer
Mar 1, 2006·Lancet·Ian B WilkinsonJohn R Cockcroft
Mar 4, 2010·European Heart Journal·Charalambos VlachopoulosChristodoulos Stefanadis
Jan 18, 2011·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Moo-Yong RheeHae-Young Kim
Oct 30, 2012·Journal of the American College of Cardiology·Julio A ChirinosPatrick Segers
Nov 29, 2012·The American Journal of Cardiology·Kavita PrasadAmit Sood
Oct 1, 2013·Atherosclerosis·Davide AgnolettiMichel E Safar
May 4, 2017·Integrative Medicine Research·Harsha NagarCuk-Seong Kim
Feb 16, 2018·The Journal of Clinical Hypertension·Giovanni ScandaleMariella Catalano
Jul 24, 2018·Physiological Measurement·Paolo SalviGianfranco Parati

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

Related Papers

Annali di medicina navale
L CONTI
The Medical Letter on Drugs and Therapeutics
Oncology
Debra Barton
© 2021 Meta ULC. All rights reserved